help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0397
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/8/3075    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Panicker, V.
Right arrow Articles by Frayling, T. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panicker, V.
Right arrow Articles by Frayling, T. M.
Related Collections
Right arrow Thyroid
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 8 3075-3081
Copyright © 2008 by The Endocrine Society

A Common Variation in Deiodinase 1 Gene DIO1 Is Associated with the Relative Levels of Free Thyroxine and Triiodothyronine

Vijay Panicker, Christie Cluett, Beverley Shields, Anna Murray, Kirstie S. Parnell, John R. B. Perry, Michael N. Weedon, Andrew Singleton, Dena Hernandez, Jonathan Evans, Claire Durant, Luigi Ferrucci, David Melzer, Ponnusamy Saravanan, Theo J. Visser, Graziano Ceresini, Andrew T. Hattersley, Bijay Vaidya, Colin M. Dayan and Timothy M. Frayling

Henry Wellcome Laboratories for Integrative Neurosciences and Endocrinology (V.P., P.S., C.M.D.) and Academic Unit of Psychiatry (J.E., C.D.), University of Bristol, Bristol BS1 3NY, United Kingdom; Faculty of Medicine, Dentistry, and Health Sciences (V.P.), University of Western Australia, Perth 6009, Australia; Genetics of Complex Traits (V.P., C.C., B.S., A.M., K.S.P., J.R.B.P., M.N.W., D.M., A.T.H., T.M.F.), Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter EX1 2LU, United Kingdom; Molecular Genetics Unit (A.S., D.H.) and Longitudinal Studies Section (L.F.), Clinical Research Branch, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892; Clinical Sciences Research Unit (P.S.), University of Warwick, Warwick CV2 2DX United Kingdom; Department of Internal Medicine (T.J.V.), Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands; Department of Internal Medicine and Biomedical Sciences (G.C.), Section of Geriatrics, University of Parma, 43100 Parma, Italy; and Department of Endocrinology (B.V.), Royal Devon and Exeter Hospital, Exeter EX2 5DW, United Kingdom

Address all correspondence and requests for reprints to: Dr. C. M. Dayan, Henry Wellcome Laboratories for Integrative Neurosciences and Endocrinology, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, United Kingdom. E-mail: Colin.Dayan{at}bristol.ac.uk.

Introduction: Genetic factors influence circulating thyroid hormone levels, but the common gene variants involved have not been conclusively identified. The genes encoding the iodothyronine deiodinases are good candidates because they alter the balance of thyroid hormones. We aimed to thoroughly examine the role of common variation across the three deiodinase genes in relation to thyroid hormones.

Methods: We used HapMap data to select single-nucleotide polymorphisms (SNPs) that captured a large proportion of the common genetic variation across the three deiodinase genes. We analyzed these initially in a cohort of 552 people on T4 replacement. Suggestive findings were taken forward into three additional studies in people not on T4 (total n = 2513) and metaanalyzed for confirmation.

Results: A SNP in the DIO1 gene, rs2235544, was associated with the free T3 to free T4 ratio with genome-wide levels of significance (P = 3.6 x 10–13). The C-allele of this SNP was associated with increased deiodinase 1 (D1) function with resulting increase in free T3/T4 ratio and free T3 and decrease in free T4 and rT3. There was no effect on serum TSH levels. None of the SNPs in the genes coding for D2 or D3 had any influence on hormone levels.

Conclusions: This study provides convincing evidence that common genetic variation in DIO1 alters deiodinase function, resulting in an alteration in the balance of circulating free T3 to free T4. This should prove a valuable tool to assess the relative effects of circulating free T3 vs. free T4 on a wide range of biological parameters.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society